He is a lousy writer, but because of his insistence I looked into what he was saying. There is a LSE Rule 3030 that allows non-disclosure of parties in a direct MM to client sale. These sales appear to be for $1.71/share. Why would anyone pay $1.71 in London for something he can buy for $0.25 on the OTC? The answer is he can't.
It may be that a fund wants in on NWBO but is prohibited by its rules from trading in the OTC and don't want to buy directly from NWBO to avoid disclosure of the purchase by NWBO. So, they contact a MM and make the purchase through the LSE (where there rules do not prohibit trading) and Rule 3030 allows for non-disclosure so long as they don't buy more than 3% of outstanding shares.
Market Data 
Markets 
